PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11850682-11	1995	We conclude the following: (1) BR is an effective antihypertensive agent; (2) BR seems to be acting at both the central and peripheric nervous systems, and (3) the nature of the dopaminergic receptor involved in renin secretion does not seem to be DA(2).	Bromocriptine	31-33	renin	Homo sapiens	212-217	
11076407-6	2000	Treatment with parlodel, agonist of dopaminergic receptors, reduced arterial pressure, prolactin level, plasma aldosterone and raised plasma renin activity in patients with microadenoma.	Bromocriptine	15-23	renin	Homo sapiens	141-146	
10099042-13	1998	We conclude from these findings that Br acts as an antihypertensive agent at peripheral and central levels by stimulating dopamine-2 receptors, which are involved in the aldosterone and renin secretion.	Bromocriptine	37-39	renin	Homo sapiens	186-191	
8520809-9	1995	At the same time bromocriptine reduced plasma aldosterone levels and plasma renin activity.	Bromocriptine	17-30	renin	Homo sapiens	76-81	
8520809-11	1995	Metoclopramide reversed the antihypertensive effect of bromocriptine and its effect on aldosterone secretion and plasma renin activity.	Bromocriptine	55-68	renin	Homo sapiens	120-125	
8520809-12	1995	We conclude from these findings that bromocriptine acts as an antihypertensive agent by stimulating DA2 dopaminergic receptor, the dopaminergic receptor involved in aldosterone and renin secretion is possibly DA2.	Bromocriptine	37-50	renin	Homo sapiens	181-186	
11850682-11	1995	We conclude the following: (1) BR is an effective antihypertensive agent; (2) BR seems to be acting at both the central and peripheric nervous systems, and (3) the nature of the dopaminergic receptor involved in renin secretion does not seem to be DA(2).	Bromocriptine	78-80	renin	Homo sapiens	212-217	
6777808-1	1980	A single oral intake of 10 mg of Bromocriptine can modify both plasma renin activity (PRA) and arterial blood pressure (BP).	Bromocriptine	33-46	renin	Homo sapiens	70-75	
11847549-3	1995	Domperidone caused an increase of both plasma renin activity and plasma aldosterone concentrations, which were reversed by bromocriptine.	Bromocriptine	123-136	renin	Homo sapiens	46-51	
2851139-4	1988	The level of cortisol raised before the start of the investigation was gradually decreased after the drug administration and reached its minimum in 2-4 h. Correlation of the basal level of aldosterone and blood renin activity, and a response of the renin-angiotensin-aldosterone system to parlodel administration was revealed.	Bromocriptine	289-297	renin	Homo sapiens	249-254	
3285838-5	1988	)-stimulated plasma renin activity and aldosterone levels were similarly decreased by bromocriptine (2.5-30 mg/d) and pergolide (50-500 micrograms/d).	Bromocriptine	86-99	renin	Homo sapiens	20-25	
438333-0	1979	Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man.	Bromocriptine	30-43	renin	Homo sapiens	51-56	
274039-3	1978	Plasma renin activity fell during institution of bromocriptine and remained significantly lower during prolonged treatment.	Bromocriptine	49-62	renin	Homo sapiens	7-12	
29242106-6	2018	We observed significant differences between bromocriptine (BROMO) and placebo (PLAC) treatments in the subgroups showing (REN) and lacking (NoREN) renewal: the renewal level of BROMO REN was significantly higher, and associated with more prominent hippocampal activation during extinction and recall, compared to PLAC REN and BROMO NoREN.	Bromocriptine	44-57	renin	Homo sapiens	122-125	
29242106-6	2018	We observed significant differences between bromocriptine (BROMO) and placebo (PLAC) treatments in the subgroups showing (REN) and lacking (NoREN) renewal: the renewal level of BROMO REN was significantly higher, and associated with more prominent hippocampal activation during extinction and recall, compared to PLAC REN and BROMO NoREN.	Bromocriptine	44-57	renin	Homo sapiens	142-145	
29242106-6	2018	We observed significant differences between bromocriptine (BROMO) and placebo (PLAC) treatments in the subgroups showing (REN) and lacking (NoREN) renewal: the renewal level of BROMO REN was significantly higher, and associated with more prominent hippocampal activation during extinction and recall, compared to PLAC REN and BROMO NoREN.	Bromocriptine	44-57	renin	Homo sapiens	142-145	
29242106-6	2018	We observed significant differences between bromocriptine (BROMO) and placebo (PLAC) treatments in the subgroups showing (REN) and lacking (NoREN) renewal: the renewal level of BROMO REN was significantly higher, and associated with more prominent hippocampal activation during extinction and recall, compared to PLAC REN and BROMO NoREN.	Bromocriptine	59-64	renin	Homo sapiens	122-125	
29100412-7	2017	Initial aldosterone-renin ratio and high metoclopramide response at baseline were independent predictors of a decrease in aldosterone secretion after a six-month course of bromocriptine.	Bromocriptine	172-185	renin	Homo sapiens	20-25